179: An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
179: An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis
-
Narrated by:
-
By:
About this listen
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Grant, MD, vice president and global program head of neuroscience and gene therapy at Swiss pharma giant Novartis, on emerging therapies for SMA.
No reviews yet